- A U.S. court ruled invalid a patent covering Pfizer Inc's blockbuster Celebrex painkiller, the drugmaker said, giving generic rivals an earlier U.S. entry that analysts estimated could cost the company $3 billion in revenue by the end of 2015.
LONDON - Swedish researchers say they have devised a blood test that could better diagnose sports-related brain injuries and prevent American football, rugby and ice hockey players returning to the field in danger.
NEW YORK (Reuters Health) - Some intrauterine devices (IUDs), already a long-term birth control option, are effective for even longer than recommended, according to a new review of past studies.
NEW YORK - A New York hospital on Wednesday alerted more than 4,200 patients who may have received insulin of possible exposure to hepatitis viruses and human immunodeficiency virus (HIV) due to possible blood contamination, officials and local media said.
WASHINGTON - There will be no delay in the penalty most Americans face under President Barack Obama's healthcare reform law if they fail to obtain health coverage this year, U.S. Health and Human Services Secretary Kathleen Sebelius said on Wednesday.
- GlaxoSmithKline Plc said its non-inhaled treatment for a type of severe asthma met the main goals in two late-stage studies.
MUMBAI - The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd's plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India's drug sector.
LONDON - Oxytocin, a brain chemical known as the "love hormone", is showing promise as a potential treatment for people with the eating disorder anorexia nervosa, according to research by British and Korean scientists.
NEW YORK (Reuters Health) - People with blood pressure that is elevated but not enough to be considered "high" are still at an increased risk for strokes, according to a new analysis of past studies.
NEW YORK (Reuters Health) - The more television children watch, the less total sleep they're getting, according to a small Spanish study.
A series that looks at all facets of cancer, written by Debra Sherman, a stage 4 lung cancer patient. Debra covered the health beat for Reuters for more than a decade and is using her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article